What Is Lipoprotein(a), or Lp(a)?

Lipoprotein(a) is a type of particle that carries fat and cholesterol through the blood, similar in some ways to LDL. What sets it apart is an extra protein attached to it, which gives it distinctive properties and its unusual name.

One of the most notable things about Lp(a) is that the level a person has is largely set by their genes. Unlike many blood fats that shift with diet and lifestyle, Lp(a) tends to stay relatively constant throughout life, which is why it is thought of as a mostly inherited trait.

Because Lp(a) is inherited and stable, clinicians typically measure it a single time to learn where a person stands, rather than tracking it again and again. That one measurement can add a layer of information to a broader cardiovascular risk assessment.

Clinicians may consider Lp(a) when there is a strong family history of early heart or blood vessel conditions, or when they want a fuller understanding of risk that standard lipid markers might not fully capture. It is generally framed as complementary information within a wider evaluation.

Higher Lp(a) has generally been associated with greater cardiovascular risk in research studies, which is why it is treated as a risk-associated marker rather than a diagnosis. Because it is largely genetic, an elevated level is often described as an inherited risk factor.

As with any marker, Lp(a) is read as one part of a larger pattern, not a verdict. Knowing that Lp(a) runs high can prompt a clinician to look more carefully at the rest of a person's risk picture and family history, and to consider how the various pieces fit together.

Lp(a) is often discussed alongside the standard lipid panel, including LDL cholesterol, HDL cholesterol, and triglycerides, as well as particle-based markers like apolipoprotein B. Each of these describes cardiovascular risk from a slightly different angle.

Because Lp(a) reflects an inherited factor that other lipid markers do not directly capture, it can add context that the rest of the panel misses. Viewing these markers together gives a clinician a more complete picture than any single one could provide.

Lp(a) is measured with a routine blood draw, typically collected at a patient service center and sent to a laboratory. Because the level is largely stable over time, a clinician often needs only a single measurement rather than repeated checks.

Once results return, a clinician interprets them in the context of family history, other markers, and a person's overall health. The result belongs inside that conversation, where a clinician can weigh what it means for the broader risk picture and what, if anything, is worth exploring next.